Submit Manuscript now
Impact Factor 4.452
Volume 11
Research Article

Prevalence of Schistosomiasis among children in Yaoundé four years after the Intervention Control and Prevention

View PDF
Editorial

Making Metabolic Dysfunction-Associated Steatotic Liver Disease Medicines Affordable: Lessons from Hepatitis C

View PDF
Research Article

Era of Interferon In HCV- Difficult Phase Is Over

View PDF
Clinical Paper

Pretransplant Malnutrition and Early Post-Transplant Mortality in Paediatric Liver Transplant Recipients: A Retrospective Cohort Analysis Using Anthropometric Z-Scores

View PDF
Case Report

Doctors Must Be Good Face Reader

View PDF
Case Report

HBV Related HCC- Points to Ponder

View PDF
https://doi.org/10.47829/JJGH.2025.11103

Prognostic Factor and Serum Biomarker Changes in Non-Surgical Hepatocellular Carcinoma Patients Treated with Radioembolization

1. Abstract
1.1: Background
Transarterial radioembolization (TARE) with 90Y is a primary therapy for hepatocellular carcinoma (HCC), including patients
with portal vein thrombosis (PVT). Patient survival subgroups post TARE have not been clearly defined.

View PDF
Clinical Image

A Non-Invasive Integrated Model for Accurate Preoperative Identification of the Aggressive Macro Trabecular-Massive Subtype of Hepatocellular Carcinoma

View PDF
Research Article

Surgical Management in Sacrococcygeal Pilonidal Sinus Disease Depending on The Suggested Staging System

1. Abstract
1.1. Background
The optimal treatment for the sacrococcygeal pilonidal disease has not been established. Recurrence rates vary by surgical technique.
Recurrence wasn’t the only factor in choosing the optimal technique. The procedure should be easy, inexpensive, have few com plications, and allow the patient to return to work or routine

View PDF
Case Report

Hepatocellular Carcinoma Revealed by Bone Metastases: A Case Report at The National Hospital and University Center in Cotonou

View PDF

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.